OpenAI and Anthropic are among the artificial intelligence companies facing a Federal Trade Commission investigation into potential risks associated with their products, CNBC reported Sept. 30, citing an agency spokesperson. The spokesperson declined to identify the other companies under investigation.…
The Latest
RUSH deployed a three-pronged strategy—data, collaboration, and real-time adjustments—to drive down readmissions across the system. Reducing readmissions ranks among the most persistent challenges health systems confront. An estimated 15% of Medicare patients return to the hospital for unplanned treatment within…
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive leaders are navigating rising costs, quality expectations and supply chain resilience. Healthcare procurement is under increasing strain as financial pressure…
Winston-Salem, N.C.-based Novant Health has named Kyle Bridges, a former congressional staffer with more than 15 years of experience in public policy and government affairs, senior vice president of government relations. Mr. Bridges will lead the health system’s government relations…
AI has moved from possibility to pressure. The question is no longer whether it matters, but which problems it should solve and how to scale without creating new clinical, financial or data risk. To understand how leading organizations are navigating…
Presented by:
This episode recorded live at the Becker’s 11th Annual Health IT + Digital Health + RCM Conference features Katherine Adams, MS, Director, Clinical Operations, Primary Care, CommonSpirit, who discusses using ambient listening, unified health records and remote patient monitoring to…
In this episode, Alex Vance, Chief Clinical Data Officer, Holmusk, discusses Holmusk’s health system partnership model, the role of its NeuroBlu database in transforming complex behavioral health data into research and insights, and how secure data collaboration can help connect…
The Medicare Advantage market remains a bit of a paradox: it may look unchanged from a national level heading into 2027, but seniors will have fewer plans to choose from in more than half of the states and growth continues…
Specialty therapies continue to transform treatment across oncology, diabetes, rare disease, and other complex disease states. From 2020 to 2025, specialty medications accounted for 75% of new drug approvals. However, developing new therapies doesn’t immediately translate into patients receiving them…
Ambient AI can help clinicians complete notes, but health systems are also looking for evidence that better documentation improves coding, revenue cycle performance and clinician capacity. In a featured session sponsored by Nabla at Becker’s 11th Annual IT + Revenue…